» Authors » Christos S Katsiotis

Christos S Katsiotis

Explore the profile of Christos S Katsiotis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 7
Citations 32
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Katsiotis C, Tikhomirov E, Leliopoulos C, Stromme M, Welch K
Eur J Pharm Biopharm . 2024 Mar; 198:114270. PMID: 38537908
Poorly soluble drugs represent a substantial portion of emerging drug candidates, posing significant challenges for pharmaceutical formulators. One promising method to enhance the drug's dissolution rate and, consequently, bioavailability involves...
2.
Katsiotis C, Tikhomirov E, Stromme M, Lindh J, Welch K
Eur J Pharm Sci . 2023 Jun; 187:106486. PMID: 37277047
Fused deposition modeling (FDM) and selective laser sintering (SLS) are two of the most employed additive manufacturing (AM) techniques within the pharmaceutical research field. Despite the numerous advantages of different...
3.
Katsiotis C, Stromme M, Welch K
Int J Pharm X . 2023 Jan; 5:100149. PMID: 36593988
The incorporation of drug-loaded mesoporous materials in dosage forms prepared with fused deposition modeling (FDM) has shown the potential to solve challenges relating to additive manufacturing techniques, such as the...
4.
Katsiotis C, Ahlen M, Stromme M, Welch K
Pharmaceutics . 2021 Aug; 13(7). PMID: 34371787
Fused deposition modelling (FDM) is the most extensively employed 3D-printing technique used in pharmaceutical applications, and offers fast and facile formulation development of personalized dosage forms. In the present study,...
5.
Eleftheriadis G, Katsiotis C, Andreadis D, Tzetzis D, Ritzoulis C, Bouropoulos N, et al.
Drug Dev Ind Pharm . 2020 Jun; 46(8):1253-1264. PMID: 32597338
Objective: The inkjet printing (IP) and fused deposition modeling (FDM) technologies have emerged in the pharmaceutical field as novel and personalized formulation approaches. Specific manufacturing factors must be considered in...
6.
Eleftheriadis G, Katsiotis C, Genina N, Boetker J, Rantanen J, Fatouros D
Expert Opin Drug Deliv . 2020 Jun; 17(8):1063-1068. PMID: 32511025
The potential of fused filament fabrication (FFF) for the administration of active pharmaceutical compounds is a recent approach to develop complex and custom-made drug delivery systems (DDSs). However, the FFF...
7.
Eleftheriadis G, Katsiotis C, Bouropoulos N, Koutsopoulos S, Fatouros D
Pharm Dev Technol . 2020 Jan; 25(4):517-523. PMID: 31903821
To this day, the oral delivery of biomacromolecules remains a major developmentally-oriented challenge. A combinatorial approach was followed at this study, to formulate an efficient carrier for the delivery of...